Markets - MarketWatch
-
AbbVie would gain an experimental eczema drug by buying biotech: report
-
‘I’ll probably be working until I die’: I’m 60, work as a waiter and have $2,000 in a Roth IRA. What will happen to me?
-
I’m 55 and retiring in 6 years. Should I be switching to Roth 401(k) contributions now?
-
The Fed is forcing Wall Street to do the heavy lifting. Use these benchmarks to find your footing.
-
SpaceX’s massive valuation may soon become its own worst enemy
-
‘Money can make you happy’: My wife and I have no heirs, but we’re making the world a better place by giving it away
-
Americans’ 401(k) balances hit record levels last year. See how you compare.
-
‘We are habitually frugal’: My wife and I have money. How do we help our children without ruining their independence?
-
Tesla booted from the ‘Magnificent Seven’ by a top fund manager. Here is the tech giant he’s crowned.
-
Employers to college students: Never mind that 4.0 GPA. Go out and get a summer job.